Recombinant LIV-1 (Ladiratuzumab Biosimilar) anticorps

N° du produit ABIN7581553

L’anticorps Human Monoclonal anti-LIV-1 (Ladiratuzumab Biosimilar) a été validé pour ELISA, BLI, FACS, Func et SPR. Il convient pour détecter LIV-1 (Ladiratuzumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant LIV-1 (Ladiratuzumab Biosimilar) anticorps (ABIN7581553)

Antigène: LIV-1 (Ladiratuzumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp LIV-1 (Ladiratuzumab Biosimilar) est non-conjugé

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Détail du produit anti-LIV-1 (Ladiratuzumab Biosimilar) anticorps

Expression System: CHO Cells

Fonction: Anti-LIV-1 / SLC39A6 Reference Antibody (ladiratuzumab)

Séquence: QVQLVQSGAE VKKPGASVKV SCKASGLTIE DYYMHWVRQA PGQGLEWMGW IDPENGDTEY GPKFQGRVTM TRDTSINTAY MELSRLRSDD TAVYYCAVHN AHYGTWFAYW GQGTLVTVSS ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE LTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW QQGNVFSCSV MHEALHNHYT QKSLSLSPG,DVVMTQSPLS LPVTLGQPAS ISCRSSQSLL HSSGNTYLEW YQQRPGQSPR PLIYKISTRF SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCFQGSHVP YTFGGGTKVE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC

Attributs du produit: Anti-LIV-1 / SLC39A6 Reference Antibody (ladiratuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Pureté: >95 %

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Therapeutic Agents by Target and Mechanism: LIV-1 inhibitors

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Stock: 4 °C,-80 °C

Stockage commentaire: +4°C,-80°C

Détails sur LIV-1 (Ladiratuzumab Biosimilar)

Antigène: LIV-1 (Ladiratuzumab Biosimilar)

Classe de substances: Biosimilar

Poids moléculaire: 145.5 kDa

UniProt: Q13433